Information  X 
Enter a valid email address
  Print      Mail a friend       More announcements

Tuesday 14 August, 2018

Progility PLC

TAKE UP UNDER THE PURCHASE FACILITY

RNS Number : 7307X
Progility PLC
14 August 2018
 

FOR IMMEDIATE RELEASE:

14 AUGUST 2018

 

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION, OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, NEW ZEALAND, THE REPUBLIC OF IRELAND, SOUTH AFRICA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL.

 

 

PROGILITY PLC

 

("Progility" or "the Company")

 

TAKE UP UNDER THE PURCHASE FACILITY

 

 

Progility plc announces that, as at 1.00p.m. on 3 August 2018, the close of the Sale Period, Praxis had received applications under the Purchase Facility, or had agreed to purchase directly, 431,631 Ordinary Shares, representing 27.02 per cent. of the issued share capital of Progility at a price of 55.0 pence per Ordinary Share. 

Taking into account the applications, agreements for purchase and its original shareholding, Praxis will own 1,465,983 Ordinary Shares representing 91.78 per cent. of the issued share capital of the Company.

Cheques will now be despatched to selling shareholders, or payment through CREST for the Purchase Facility will be made on or about 20 August 2018.

Terms in this announcement have the same meaning as in the Circular to Shareholders dated 22 June 2018.

For further information, please contact:

Progility plc

Wayne Bos

Executive Chairman

020 7371 4444

www.progility.com

 

SPARK Advisory Partners Limited

Mark Brady

020 3368 3551

 

 

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
MSCGGURWRUPRUMC

a d v e r t i s e m e n t